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Abstract 
Background: Metabolic syndrome (MetS) is a clustering of cardiovascular risk factors, which is rising in the low and 
middle income countries (LMICs). There are various studies with inconsistent findings that are inconclusive for policy 
makers and program planners. Thus, this systematic review and meta-analysis aimed at estimating the pooled preva-
lence of MetS and its components in LMICs.
Methods: Electronic searches were conducted in international databases including PubMed, Web of Science, 
EMBASE (Elsevier), Scopus, CINAHL (EBSCOhost), Science direct (Elsevier), Food Science and Technology Abstracts 
(FSTA), Global Health and Medline, and other sources (World Cat, Google Scholar, and Google). The pooled estimates 
were computed in the random effect model. The pooled prevalence was computed using the three diagnostic meth-
ods (IDF, ATP III and de Ferranti). Publication bias was verified using funnel plot and Egger’s regression test. Subgroup 
and sensitivity analysis were performed to identify the possible sources of heterogeneity among the included studies.
Result: In this study, 142,142 children and adolescents from 76 eligible articles were included to compute the pooled 
prevalence of MetS and its components in LMCIs. MeTs among overweight and obese population was computed 
from 20 articles with the pooled prevalence of 24.09%, 36.5%, and 56.32% in IDF, ATP III and de Ferranti criteria, respec-
tively. Similarly, a total of 56 articles were eligible to compute the pooled prevalence of MetS in the general popula-
tion of children and adolescents. Hence, Mets was found in 3.98% (IDF), 6.71% (ATP III) and 8.91% (de Ferranti) of study 
subjects. Regarding the components of MetS, abdominal obesity was the major component in overweight and obese 
population and low HDL-C was the most common component in the general population. This study also revealed 
that males were highly affected by MetS than females.
Conclusion: This study illustrates that MetS among children and adolescents is an emerging public health chal-
lenge in LMICs, where the prevalence of obesity is on the move. Preventive strategies such as community and school 
based intervention need to be designed. Promoting physical activities and healthy eating behaviors could avert this 
problem.
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Background
Metabolic syndrome (MetS) is a constellation of inter-
connected risk factors of metabolic origin leading to 
atherosclerotic cardiovascular diseases [1]. The com-
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glucose metabolism, reduced high density lipoprotein 
cholesterol (HDL-C), and elevated blood pressure and 
adiposity [2]. It usually resulted from dysregulated cel-
lular metabolism, leading to insulin resistance [3]. MetS 
is also associated with a multitude of disorders such 
as diabetic mellitus, increased uric acid level, hepatic 
steatosis, polycystic ovarian syndrome, and obstructive 
sleep apnea [4–8].
There are various diagnostic methods for MetS in chil-
dren and adolescents. According to the International 
Diabetes Federation (IDF), MetS is diagnosed if children 
aged between 10–16 years have central adiposity (≥ 90th) 
and two of the followings: triglycerides (TG) ≥ 150  mg/
dl, HDL-C < 40  mg/dl, systolic blood pressure 
(BP) ≥ 130  mmHg or diastolic BP ≥ 85  mmHg, fasting 
plasma glucose (FG) ≥ 100 mg/dl or previously diagnosed 
type 2 diabetes [9]. Based on the WHO criteria, MetS is 
diagnosed when three or more of the following features 
are found: body mass index (BMI): > 95th percentile, 
hyperinsulinemia or impaired fasting glucose or impaired 
glucose tolerance, BP > 95th percentile, TG > 105/136 mg/
dL (1.2/1.5 mmol/L) for children aged < 10 and > 10 years 
respectively, HDL-C < 35 mg/dL (0.9 mmol/L) [10]. Adult 
Treatment Panel III (ATPIII) criteria modified for age 
defines the presence of MetS when three of the follow-
ing criteria are met: TG ≥ 110  mg/dl, HDL-C ≤ 40  mg/
dl, systolic BP or diastolic BP ≥ 90th, WC ≥ 90th percen-
tile for age and gender. percentile for age and gender and 
FG ≥ 110 mg/dl [11]. In accordance with de Ferranti et al. 
MetS is clustering of at least three of the following cri-
teria: FG ≥ 110 mg/dl, HDL-C ≤ 50 mg/dl (except in boys 
aged 15 to 19 years in whom the cut point is 45 mg/dl), 
TG ≥ 100 mg/dl, systolic BP > 90th percentile for gender, 
age and height, WC > 75th percentile for age and gender 
[12], whereas Cook et al. depicted that MetS is diagnosed 
when there or more of the following criteria are met: 
WC ≥ 90th percentile, FG ≥ 110  mg/dL (≥ 6.1  mmol/L), 
TG ≥ 110 mg/dL, HDL-C ≤ 40 mg/dL (1.03 mmol/L) and 
BP ≥ 90th percentile [13].
The prevalence of MetS in children and adoles-
cents remains unclear [14]. However, a previous review 
revealed that it ranged from 0.2 to 38.9%, with a median 
of 3.3% (range, 0–19.2) in the general population and 
relatively higher in overweight (11.9%) and obese (29.2%) 
children [14–16]. These reports depicted that MetS in 
children and adolescents is increasingly becoming a 
major public health concern [17]. Accordingly, study 
findings concerning MetS among children and ado-
lescents reported in low and middle-income countries 
(LMICs), are highly inconsistent and varied across coun-
tries. For instance, it is estimated to be as high as 22% in 
Iranian children and adolescents with sizable variations 
among the diagnostic methods [18].
A previous study has outlined that plenty of factors, 
primarily related to lifestyle [19], are significantly associ-
ated with an increased incidence of MetS. Consumption 
of fructose in the form of soft drinks, juice, and baked 
goods remarkably upsurge in the past four decades, 
which contributed to the emergence of obesity, the main 
predictor of MetS in children and adolescents [20–22]. 
It has significantly increased since 1980 contributing to 
6–39% of MetS in children and adolescents [23]. Cur-
rently, obesity is one from the three global syndemics 
along with undernutrition and climate change, affecting 
both children and adults globally [24]. This problem is 
increasing alarmingly in developing countries due to the 
recent nutritional and demographic transitions [25].
Evidence-based systematic reviews are essential to 
inform program planners and policy-makers. However, 
to the best of our knowledge, systematic reviews in this 
area are minimal, especially in LMICs. Therefore, the 
main purpose of this systematic review and meta-anal-
ysis was to determine the pooled prevalence of MetS in 
children and adolescents in LMICs using different diag-
nostic methods. The findings will be very informative for 
policy-makers and program planners in designing pre-
ventive strategies accordingly. The results will also have 
a particular implication for developing countries, where 
the triple burden of malnutrition prevails [26]. Besides, 
this study will be decisive to design preventive measures 
for non-communicable diseases (NCDs) in the LMICs, 
where the trend of NCDs is increasing.
Methods
Eligibility criteria and information sources
In this systematic review and meta-analysis, studies 
conducted in LMICs with an objective of assessing the 
prevalence of MetS among children and adolescents 
were included. The studies were assessed using study 
area, study setups, title, abstract, and full texts prior to 
inclusion in this study. This study was prepared based 
on the Preferred Reporting Items for Systematic Reviews 
and Meta-analysis (PRISMA) guideline [27]. In the pre-
sent study, published articles, surveys, and unpublished 
articles that were conducted in English were explored 
and included accordingly. Besides, the reference lists of 
included articles were checked for additional studies. 
Observational studies reporting the prevalence of MetS 
among children and adolescents conducted both in clini-
cal and community based setups were included. Studies 
published until July, 2020 were searched.
However, articles with incomplete diagnostic methods 
and which were not fully accessible were excluded. The 
corresponding authors of the primary studies were com-
municated by email before the decision of exclusion was 
made. Conference proceedings and qualitative studies 
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were also excluded. The EndNote X8 reference manager 
was used to manage retrieved articles.
Search strategy and study selection
A comprehensive systematic literature search was con-
ducted by three investigators (ZWB, AA, and TW), inde-
pendently. During the searching process, we consulted 
a senior librarian working at St. Paul’s Hospital Millen-
nium Medical College, Ethiopia A literature search for 
available articles published in English was performed 
using the following databases: PubMed, Web of Science, 
EMBASE (Elsevier), Scopus, CINAHL (EBSCOhost), 
Science direct (Elsevier), Food Science and Technology 
Abstracts (FSTA), Global Health and Medline, up to July 
2020. The grey literature sources (World Cat, Google 
Scholar, and Google) were also explored to find out addi-
tional articles. Searching was conducted using the fol-
lowing key terms: (a) population (children, adolescent, 
child, school age); (b) exposure (associated factors, risk 
factors, determinants, predictors) (c) outcome (metabolic 
syndrome, MetS, components of metabolic syndrome); 
(d) study design (cohort studies, cross sectional studies, 
epidemiology, observational, national health surveys); (e) 
study setting (school, community based surveys, health 
institutions) and (f ) location (low and middle-income 
countries, LMICs, developing countries, names of low 
and middle income countries). The Boolean search oper-
ators such as “OR”, “AND” were used during the search-
ing process. Key terms were verified for appropriateness 
prior to actual searching. Example of search string in 
PubMed (Table 1). 
Data extraction process
Three authors (ZWB, AA, and EGA) extracted data 
from included articles using a standardized data extrac-
tion form. First, the data were stored in Microsoft excel, 
2016 by two authors (ZWB, AA, and EGA), indepen-
dently. Next, the data were cleaned and made ready for 
the final analysis using the excel spreadsheet. Finally, the 
data were exported to the STATA software for analysis. 
The data extraction format included: name of the author 
(s), publication year, study country, sample sizes, age of 
the study population, population group, MetS with diag-
nostic methods, and components of MetS. Discrepan-
cies between the authors were solved through discussion 
and consensus, and with active involvement of the other 
author (ZT) (Additional file 1).
Table 1 Search string used for searching articles from Pubmed
Population (Children) OR (school children)) OR ("Child"[Mesh])) OR ("Adolescent"[Mesh])
Outcome ("Prevalence"[Mesh] AND "epidemiology" [Subheading]) AND ("Metabolic Syndrome"[Mesh])
Study region/country (low and middle income countries)) OR "Afghanistan"[Mesh]) OR ("Burkina Faso"[Mesh])) OR ("Burundi"[Mesh])) 
OR ("Central African Republic"[Mesh])) OR ("Chad"[Mesh])) OR ("Democratic Republic of the Congo"[Mesh])) OR 
("Eritrea"[Mesh])) OR ("Ethiopia"[Mesh])) OR ("Gambia"[Mesh])) OR ("Guinea"[Mesh])) OR ("Guinea-Bissau"[Mesh])) OR 
("Haiti"[Mesh])) OR ("Democratic People’s Republic of Korea"[Mesh])) OR ("Liberia"[Mesh])) OR ("Madagascar"[Mesh])) 
OR ("Malawi"[Mesh])) OR ("Mali"[Mesh])) OR ("Mozambique"[Mesh])) OR ("Niger"[Mesh])) OR ("Rwanda"[Mesh])) OR 
("Sierra Leone"[Mesh])) OR ("Somalia"[Mesh])) OR ("South Sudan"[Mesh])) OR ("Sudan"[Mesh])) OR ("Syria"[Mesh])) 
OR ("Tajikistan"[Mesh])) OR ("Togo"[Mesh])) OR ("Uganda"[Mesh])) OR ("Yemen"[Mesh])) OR ("Angola"[Mesh]))) OR 
"Bangladesh"[Mesh]) OR ("Benin"[Mesh])) OR ("Bhutan"[Mesh])) OR ("Bolivia"[Mesh])) OR ("Cabo Verde"[Mesh])) OR 
("Cambodia"[Mesh])) OR ("Cameroon"[Mesh])) OR ("Comoros"[Mesh])) OR ("Congo"[Mesh])) OR ("Cote d’Ivoire"[Mesh])) 
OR ("Djibouti"[Mesh])) OR ("Egypt"[Mesh])) OR ("El Salvador"[Mesh])) OR ("Eswatini"[Mesh])) OR ("Ghana"[Mesh])) OR 
("Honduras"[Mesh])) OR ("India"[Mesh])) OR ("Kenya"[Mesh])) OR ("Micronesia"[Mesh])) OR ("Kyrgyzstan"[Mesh])) OR 
("Lesotho"[Mesh])) OR ("Mauritania"[Mesh])) OR ("Moldova"[Mesh])) OR ("Mongolia"[Mesh])) OR ("Morocco"[Mesh])) 
OR ("Myanmar"[Mesh])) OR ("Nepal"[Mesh])) OR ("Nicaragua"[Mesh])) OR ("Nigeria"[Mesh])) OR ("Pakistan"[Mesh])) OR 
("Papua New Guinea"[Mesh])) OR ("Philippines"[Mesh])) OR ("Sao Tome and Principe"[Mesh])) OR ("Senegal"[Mesh])) 
OR ("Melanesia"[Mesh])) OR ("Sri Lanka"[Mesh])) OR ("Tanzania"[Mesh])) OR ("Timor-Leste"[Mesh])) OR ("Tunisia"[Mesh])) 
OR ("Ukraine"[Mesh])) OR ("Uzbekistan"[Mesh])) OR ("Vanuatu"[Mesh])) OR ("Vietnam"[Mesh])) OR ("Middle 
East"[Mesh])) OR ("Zambia"[Mesh])) OR ("Zimbabwe"[Mesh])) OR ("Albania"[Mesh])) OR ("American Samoa"[Mesh])) 
OR ("Argentina"[Mesh])) OR ("Armenia"[Mesh])) OR ("Azerbaijan"[Mesh])) OR ("Republic of Belarus"[Mesh])) 
OR ("Belize"[Mesh])) OR ("Bosnia and Herzegovina"[Mesh])) OR ("Botswana"[Mesh])) OR ("Brazil"[Mesh])) OR 
("Bulgaria"[Mesh])) OR ("China"[Mesh])) OR ("Colombia"[Mesh])) OR ("Costa Rica"[Mesh])) OR ("Cuba"[Mesh])) 
OR ("Dominica"[Mesh])) OR ("Dominican Republic"[Mesh])) OR ("Dominican Republic"[Mesh])) OR ("Equatorial 
Guinea"[Mesh])) OR ("Ecuador"[Mesh])) OR ("Fiji"[Mesh])) OR ("Gabon"[Mesh])) OR ("Georgia (Republic)"[Mesh])) 
OR ("Grenada"[Mesh])) OR ("Guatemala"[Mesh])) OR ("Guyana"[Mesh])) OR ("Indonesia"[Mesh])) OR ("Iran"[Mesh])) 
OR ("Iraq"[Mesh])) OR ("Jamaica"[Mesh])) OR ("Jordan"[Mesh])) OR ("Kazakhstan"[Mesh])) OR ("Kosovo"[Mesh])) OR 
("Lebanon"[Mesh])) OR ("Libya"[Mesh])) OR ("Malaysia"[Mesh])) OR ("Indian Ocean Islands"[Mesh])) OR ("Mexico"[Mesh])) 
OR ("Montenegro"[Mesh])) OR ("Namibia"[Mesh])) OR ("Republic of North Macedonia"[Mesh])) OR ("Paraguay"[Mesh])) 
OR ("Peru"[Mesh])) OR ("Russia"[Mesh])) OR ("Samoa"[Mesh])) OR ("Serbia"[Mesh])) OR ("South Africa"[Mesh])) OR 
("Saint Lucia"[Mesh])) OR ("Suriname"[Mesh])) OR ("Thailand"[Mesh])) OR ("Tonga"[Mesh])) OR ("Turkey"[Mesh])) OR 
("Turkmenistan"[Mesh])) OR ("Venezuela"[Mesh]))
Filters Filters: Free full text, Observational Study, in the last 10 years, Humans, English, Child: 6–12 years, Adolescent: 13–18 years
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Quality assessment of studies
Two authors (ZWB & AA) independently assessed the 
quality of included studies using a Joanna Briggs Insti-
tute (JBI) Critical Appraisal Checklist for Observa-
tional Studies [28]. The tool has four options (Yes, No, 
Unknown, and Not Applicable). One is given for yes and 
zero for other options. The minimum score was zero and 
the maximum was eight. The scores were summed up 
and changed to percentages. Studies with quality scores 
of > 50% were included in this meta-analysis (Addi-
tional file 2). The mean scores of the two reviewers were 
used for final decision of inclusion of the studies in this 
systematic review and meta-analysis. During critical 
appraisal, the author (ZT) participated actively in solving 
differences between the two authors.
Summary measures
The primary outcome of this study was the prevalence of 
MetS among children and adolescents in LMICs using 
various diagnostic methods. The pooled prevalence of 
MetS was calculated in the general population and over-
weight and/or obese children and adolescents separately. 
The general population includes underweight, normal 
weight, overweight and obese children and adolescents. 
The other outcomes were components of metabolic syn-
dromes, the prevalence of MetS based on country, conti-
nent, and economic level of countries, where the original 
studies were done. Based on economic level, LMICs were 
further divided in to low income economies (LIE), lower 
middle income economies (LMIE), and upper middle 
income economies (UMIE) [29]. The pooled prevalence 
of MetS was also computed among males and females. 
The prevalence was calculated by dividing the total num-
ber of events (MetS) to the total sample size and multi-
plying it by 100. The binomial distribution formula was 
used to compute the standard error for each original 
study. The “metan” commands were used to compute the 
pooled estimates using STATA (version 15) software. The 
pooled estimates were presented with their 95% CIs. The 
effect sizes were prevalence of MetS in LMICs and the 
respective components of MetS.
Statistical methods and analysis
In the current meta-analysis, STATA Version 15 (STATA 
Corporation, College Station Texas) software was used 
for computing the pooled estimates. The pooled esti-
mates were computed using both random and fixed effect 
models. Due to the presence of high heterogeneity among 
studies, the pooled estimates were computed using ran-
dom-effects models and were weighted using the inverse 
variance method. Subgroup analyses were performed 
using different parameters. The pooled estimates in the 
general and overweight and/or obese population were 
presented separately. For the subgroup analysis, data 
were extracted based on study continent, study county, 
the economic level of the study countries, type of diagno-
sis and gender of study subjects. The appropriateness of 
each datum was verified before the analyses. The pooled 
estimates were presented with their 95% CIs. Likewise, 
the heterogeneities among the included studies in the 
pooled estimates were presented with  I2 test statistic and 
P-value. The results of meta-analyses were presented 
using forest plot, summery tables, and texts.
Publication bias and heterogeneity
Publication bias was assessed using the funnel plot asym-
metry and Egger’s regression test at a 5% significant level 
[30]. Heterogeneity among included studies was explored 
using forest plot,  I2 test, and the Cochrane Q statistics 
[31]. The  I2 values of 25%, 50%, and 75% were interpreted 
as low, medium, and high heterogeneity, respectively [32]. 
In this meta-analysis, significant heterogeneity was con-
sidered when the  I2 value was ≥ 50%, with P-value < 0.05. 
The possible sources of significant heterogeneity were 
addressed through sub-group and sensitivity analyses.
Results
Selection of eligible studies
A total of 4597 articles were obtained in the initial 
search. After removal of 478 due to duplicates, 4119 were 
remained and screened for titles and abstracts. Following 
this, 4018 studies were removed after reading titles and 
abstracts. The full texts of 101 articles were downloaded 
and assessed for eligibility criteria. Twenty five studies 
were excluded due to the following exclusion criteria: dif-
ferent study population, no full test, unclear diagnostic 
criteria, letter to editor, written in non-English language, 
and different study design (Additional file 3). Finally, 76 
articles [33–108] were included in the final analysis in 
this meta-analysis (Fig. 1).
Characteristics of the included studies
All studies included in this study were cross-sectional 
studies. Regarding study population, 20 studies [35, 47, 
50, 55, 57, 58, 63, 69, 71, 72, 77, 79, 84, 87–89, 91, 92, 95, 
104] were conducted among overweight and/or obese 
children and adolescents, and 56 studies [33, 34, 36–46, 
48, 49, 51–54, 56, 59–62, 64–68, 70, 73–76, 78, 80–83, 85, 
86, 90, 93, 94, 96–103, 105–108] were conducted among 
the general population of children and adolescents. 
This review included 142,142 study participants from 
76 articles. Of which, 138,236 were the general popula-
tion, whereas 3906 were overweight and obese popula-
tion. The sample size of included studies ranged from 51 
in Tunisia [58] to 37,504 in Brazil [52]. The age of study 
population across the included studies ranged between 5 
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to 20 years. Most of the studies were conducted in UMIE 
Asian countries and very few articles were found from 
Africa. The quality of articles was also assessed using the 
JBI checklist, and 56 articles had medium quality. The 
remaining 20 studies had high quality (Tables 2, 3).
Prevalence of MetS and components among overweight 
and obese children and adolescents
The pooled prevalence of MetS was estimated based on 
the three diagnostic methods (IDF, ATP III and de Fer-
ranti). A total of 14 articles [35, 47, 55, 58, 63, 69, 72, 77, 
79, 87–89, 92, 95] were eligible to compute the pooled 
prevalence of MetS in the IDF criteria. Accordingly, 
24.1% (95% CI 16.90, 31.29,  I2 = 96.6%) of the study sub-
jects were found to have MetS. Abdominal obesity was 
the most common (60.9%) component of MetS, whereas 
high FG level was the least (10.3%) component. Accord-
ing to the modified ATP III, the pooled prevalence of 
MetS was 36.51% (95% CI − 1.76, 74.78,  I2 = 99.8%). 
It was computed using eight articles [50, 57, 63, 71, 77, 
84, 89, 104]. Two thirds (67.2%) of the children and 
adolescents were found to have abdominal obesity, 
but very few (3.4%) of them had high FG level. Besides, 
only two articles [89, 91] were eligible to estimate the 
pooled prevalence of MetS (56.32%, 95% CI 22.34, 90.29, 
 I2 = 94.4%) among overweight and/or obese children and 
adolescents in accordance with de Ferranti criteria. Simi-
larly, abdominal obesity and high FG level were the most 
(91.2%) and least (7.75%) components of MetS in the de 
Ferranti diagnostic criteria.
The pooled prevalence of MetS was also computed 
based on gender. The prevalence of MetS was relatively 
higher in males (26.63%) than females (24.05%) in the IDF 
method. Likewise, males (33.37%) were highly affected 
by MetS than females (31.4%) according to the modified 
ATP III diagnostic criteria (Fig. 2 & Table 4).
Prevalence of MetS & components in the general 
population of children & adolescents
The pooled prevalence of MetS was estimated in LMICs 
using the IDF, ATP III and de Ferranti diagnostic meth-
ods. A total of 30 [33, 36–38, 40–44, 46, 48, 51, 52, 54, 
Studies identified through data base 
searching (4484) 
PubMed= 3888    Web of Science=50 
EMBASE=38        Scopus=42 
CINAHL=43         Science direct=317 
FSTA=69                Global Health=6 
Medline=31 
Studies after duplicated studies were removed  
(n=4119) 
Full texts of studies assessed for 
eligibility  
(n=101) 
76 studies were included in this systematic 
review & meta-analysis (20 studies for 
overweight and/or obese study subjects and 
 f r h n r l l i n
Studies excluded by title 
and abstract (n=4018) 
Duplicated Studies  
n=478
Full texts studies excluded 
(n=25) 
- different population (5) 
- unclear diagnosis criteria (8) 
- full nexts not available (5) 
- different language (2) 
- different stud  desi n 5
Articles obtained from other 
sources=113  
Fig. 1 PRISMA flow chart showing study selection process
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60, 62, 68, 70, 73–75, 78, 80, 81, 83, 85, 90, 94, 98, 102], 
33 [34, 39, 42, 43, 51, 53, 56, 59–62, 65–67, 73–76, 82, 
85, 86, 93, 96–102, 105–108], and 8 [42, 45, 49, 51, 64, 
75, 78, 103] articles were eligible to compute the pooled 
estimates in the IDF, ATP III and de Ferranti diagnostic 
criteria, respectively.
According to the IDF criteria, the pooled prevalence 
of MetS among the general population of children and 
adolescents was 3.98% (95% CI 3.35, 4.61,  I2 = 97.8%). 
The pooled estimate in males (3.46%; 95% CI 2.69, 4.23, 
 I2 = 97.6%) was relatively higher than females (2.99%; 
95% CI 2.34, 3.65,  I2 = 95.6%). From the components, low 
HDL-C level was the commonest (27.93%) and high FG 
(7.78%) was the infrequent one.
Similarly, 6.71% (95% CI 5.51, 7.91,  I2 = 97.6%) study 
subjects were found to have MetS in the ATP III criteria. 
MetS among males (6.24%; 95% CI 4.89, 7.59,  I2 = 93.9%) 
and females (6.51%; 95% CI 4.99, 8.03,  I2 = 95.8%) was 
nearly the same. Low HDL-C was seen in one third 
(31.3%; 95% CI 23.89, 38.72,  I2 = 99.7%) of study subjects 
and high FG in 6.1% (95% CI 5.02, 7.15,  I2 = 98.7%) of 
study subjects.
Besides, the pooled prevalence of MetS in children 
and adolescents with de Ferranti diagnostic method was 
8.19% (95% CI 5.58, 10.79,  I2 = 96.2%) with similar preva-
lence in males (8.78%; 95% CI 5.45, 12.12,  I2 = 94.3%) 
and females (8.51%; 95% CI 5.21, 11.75,  I2 = 93.7%). The 
pooled estimate of low HDL-C was 45.83% (95% CI 
34.53, 57.14,  I2 = 99.1%), the highest, and only 2.12% (95% 
CI 1.15, 3.08,  I2 = 94.7%) of the population had a high FG 
level (Fig. 3 & Table 5).
Subgroup analysis of the pooled prevalence of MetS 
in the general population
The subgroup analyses were performed for the two 
diagnostic methods (IDF and ATP III) using the two 
parameters (income level and continent). In the IDF 
diagnostic method, the pooled estimate of MetS in LIE, 
LMIE and UMIE countries were estimated. The preva-
lence of MetS in LIEs (12.4%, 95% CI 10.5, 14.65) was 
computed from one study. Likewise, the pooled esti-
mates of MetS in LMIE (6.91%; 95% CI 2.35, 11.46, 
 I2 = 98.2%) and UMIE (3.51%; 2.88, 4.14,  I2 = 97.7%) 
countries were computed from three and 26 articles, 
respectively. Regarding the continent where the origi-
nal studies were conducted, only three articles were 
from Africa, seven articles from Latin America and 
the majorities (20) articles were from Asia. The pooled 
prevalence of MetS in Africa, Asia and Latin America 
were 6.03% (95% CI 0.24, 11.28,  I2 = 94.7%), 4.39% (95% 
CI 3.50, 5.29,  I2 = 98%), and 2.46% (95% CI 1.29, 3.64, 
 I2 = 97.8%), respectively (Fig. 4).
According to the ATP III diagnostic method, the 
pooled prevalence of MetS in countries classified under 
LMIE and UMIE was estimated from eight and 25 eli-
gible articles, respectively. Accordingly, 5.73% (95% CI 
3.72, 7.74,  I2 = 95.9%) of the study subjects in LMIEs 
and 7% (95% CI 5.53, 8.48,  I2 = 96.8%) in UMIE coun-
tries were found to have MetS. The pooled prevalence 
of MetS in Africa, Latin America and Asia was com-
puted from two, eight and 23 articles, respectively. 
Thus, 6.71% (95% CI 5.51, 7.91,  I2 = 0.00%) in Africa, 
5.19% (95% CI 3.31, 7.05,  I2 = 95.3%) in Latin America 
and 7.24% (95% CI 5.64, 8.84%,  I2 = 96.9%) in Asia had 
MetS (Fig. 5).
Publication bias and sensitivity analysis
Due to the presence of high heterogeneity among the 
included articles, the possible sources of variation were 
further explained. Thus, the funnel plots for both IDF 
and ATP III diagnostic criteria were presented (Fig. 6). 
The asymmetry of plots was objectively verified by 
Egger’s regression test and there was publication bias 
among the articles included in computing the pooled 
prevalence of MetS in the IDF criteria (P = 0.001), 
whereas the Egger’s regression test revealed that there 
was no publication bias in the pooled estimate of ATP 
III diagnostic criteria (P = 0.063). Moreover, sensitivity 
analysis was computed for both diagnostic methods. 
This was done to evaluate if the pooled estimates were 
altered by the exclusion of any single study. However, 
none of the studies had significant effects in the pooled 
estimates (Fig. 7).
Finally, the prevalence of MetS in LMICs among the 
general population children and adolescents was plotted 
in linear graph using the number of cases with publica-
tion year (2004 to 2020). The graph depicted that there is 
an increasing trend in the two diagnostic methods (IDF 
& de Ferranti) and the reverse was true in ATP III criteria 
(Fig. 8).
Discussion
To the authors’ knowledge, this is the first comprehen-
sive systematic review and meta-analysis, determining 
the prevalence of metabolic syndrome among children 
and adolescents in LMICs. In this study, the pooled 
prevalence of MetS was computed using three diagnostic 
methods: IDF, ATP III & de Ferranti. Seventy six articles 
with 142,142 participants were included in this meta-
analysis. Of the total studies, 56 were conducted among 
the general population of study subjects, and 20 were 
conducted among overweight and/or obese children and 
adolescents.
The current meta-analysis revealed that the preva-
lence of MetS among overweight and obese population 
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is remarkably higher than the general population of chil-
dren and adolescents. The pooled prevalence of MetS 
in the overweight and obese children and adolescents is 
as follows: IDF: 24.1%, ATP III: 36.5% and de Ferranti: 
56.32%. Whereas, it is 3.98%, 6.71% and 8.19% with the 
IDF, ATP III and de Ferranti diagnostic methods, respec-
tively in the general population. The prevalence in the 
general population is comparable with a review done in 
Iran, where the prevalence of MetS was 0–8%, 3–16%, 
and 0–22% in the IDF, ATP III and de Ferranti crite-
ria, respectively [18]. However, the current prevalence 
among the overweight and obese population is consid-
erably higher than the Iranian review findings [18]. The 
possible explanation for this variation could be due to 
the fact that overweight and obese children are at greater 
risk of developing metabolic syndrome as compared to 
children with normal weight [20]. The present findings 
are also in line with the previous review findings which 
reported that the prevalence of MetS in the pediatric 
population ranged from 1.2–22.6% [109] to 0–19.2% 
[15] irrespective of the specific diagnostic methods. The 
median prevalence of MetS in the world was 3.3% in 2007 
to 2009, which is lower than the all pooled estimates in 
this meta-analysis [15]. The prevalence of MetS is also 
considerably higher than a meta-analysis findings done 
in Chinese children and adolescents, where 1.8% (IDF) 
and 2.6% (ATP III) were found to have MetS [110]. This 
implies that MetS is increasing throughout the world, 
including in LMICs and it is supported by the previous 
reviews [14, 111, 112].
Regarding gender based distribution; the prevalence of 
MetS in males is relatively higher than in females in most 
of the diagnostic methods. The prevalence among over-
weight and obese males is 26.63% (IDF) and 33.37% (ATP 
III), and it is 24.05% (IDF) and 31.4% (ATPIII) among 
females. Similarly, the prevalence of MetS among males 
(3.46%) in the general population is higher as compared 
to females (2.99%) with IDF criteria. However, the pooled 
prevalence of MetS among males and females in the gen-
eral population of children and adolescents is approxi-
mately similar in the two diagnostic methods (ATPIII & 
de Ferranti). The prevalence in males is 6.24% (ATPIII) 
and 8.78% (de Ferranti); and it is 6.51% (ATPIII) and 
8.51% (de Ferranti) among females. In general, males are 
at greater risk to have MetS than females. This finding is 
supported by most of the original studies included in this 
meta-analysis and the other meta-analysis done in china 
[110]. The possible justification for gender disparities 
Table 4 Pooled prevalence of MetS & components in overweight & Obese children and adolescents
REM, random effect model; FEM, fixed effect model
Variables Characteristics # of studies Pooled prevalence, (95% CI) Heterogeneity 
 (I2(%), P-value))
Model
Diagnostic Criteria IDF 14 24.09 (16.90, 31.29) 96.6, P ≤ 0.001 REM
ATP III 8 36.51 (− 1.76, 74.78) 99.8, P ≤ 0.001 REM
de Ferranti 2 56.32 (22.34,90.29) 94.4, P ≤ 0.001 REM
Components of MetS (IDF) Abdominal Obesity 12 60.90 (46.63,75.16) 99.7, P ≤ 0.001 REM
Low HDL-C 13 34.83 (23.8, 46.48) 98.0, P ≤ 0.001 REM
High TG 12 18.59 (13.21,23.98) 93.0, P ≤ 0.001 REM
High FG 13 10.27 (6.67,13.87) 95.9, P ≤ 0.001 REM
Elevated BP 13 23.88 (17.29, 30.47) 99.8, P ≤ 0.001 REM
Components of MetS (ATPIII) Abdominal Obesity 8 67.20 (49.45,84.95) 98.9, P ≤ 0.001 REM
Low HDL-C 8 42.48 (33.45, 51.51) 99.8, P ≤ 0.001 REM
High TG 8 38.85 (27.61, 50.10 92.9, P ≤ 0.001 REM
High FG 7 3.39 (1.05,5.74) 81.4, P ≤ 0.001 REM
Elevated BP 8 29.56 (15.03, 44.8) 96.9, P ≤ 0.001 REM
Components of MetS (de Ferranti) Abdominal Obesity 2 91.20 (80.42, 101.98) 95.6, P ≤ 0.001 REM
Low HDL-C 2 62.29 (2.91, 121.68) 99.7, P ≤ 0.001 REM
High TG 2 42.40 (38.39, 46.40) 0.00, P = 0.632 FEM
High FG 2 7.75 (− 4.20, 19.71) 97.3, P ≤ 0.001 REM
Elevated BP 2 53.04 (8.25, 97.82) 99.1, P ≤ 0.001 REM
Gender (IDF) Male 10 26.63 (23.95, 29.31) 99.3, P ≤ 0.001 REM
Female 10 24.05 (16.65, 31.45) 90.7, P ≤ 0.001 REM
Gender (ATPIII) Male 5 33.37 (19.68, 47.06) 99.5, P ≤ 0.001 REM
Female 5 31.40 (15.43, 47.36) 99.8, P ≤ 0.001 REM
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could be related to higher prevalence of obesity in males 
than females. This could be further explained by the fact 
that males usually consume excessive energy due to self 
and family perceived underweight and underestimation 
of their weight. On the contrary, female adolescents con-
trol their weight through diet and physical activity due to 
self-perceived overweight [113]. But, further exploration 
is needed with experimental studies.
The pooled prevalence of the components of MetS was 
also computed in each of the diagnostic methods and 
considerable numbers of study subjects were found to 
have each of the five components. Abdominal obesity is 
found to be the commonest component of MetS in over-
weight and obese children, with a pooled prevalence of 
60.9% (IDF), 67.2% (ATP III), and 91.2% (de Ferranti). In 
contrary, a high FG level was the most infrequent com-
ponent of MetS with a pooled prevalence of 10.3% (IDF), 
3.4% (ATP III), and 7.75% (de Ferranti). Besides, the 
pooled prevalence of low HDL-C is the most prevalent 
component of MetS among the general population. It was 
found in 27.93% (IDF), 31.3% (ATP III) and 45.83% (de 
Ferranti) of the study population. But, high FG is the least 
component in IDF (7.78%) and de Ferranti (2.12%) crite-
ria. Likewise, abdominal obesity is the least (4.46%) com-
ponent in the ATP III criteria. All the other component 
of MetS in overweight and obese children is considerably 
higher as compared to the pooled prevalence in the gen-
eral population. The possible elucidation could be due 
to a multitude of factors like consumption of unhealthy 
diets (Western type of diets), diets low in fruit, vegeta-
bles, fruits and grains [114, 115].
Moreover, children and adolescents from countries 
with UMIEs are found to have a lower risk of developing 
MetS than children from countries classified under LIE 
Table 5 The pooled prevalence of MetS and components in the general population
a Others: underweight and normal weight, REM, Random Effect Model; de F., de Ferranti
Variables Characteristics # included 
articles
Pooled prevalence (95%, CI) Heterogeneity  (I2 
(%), P-value)
Model
Diagnostic Criteria IDF 30 3.98 (3.35,4.61) 97.8, P ≤ 0.001 REM
ATP III 33 6.71 (5.51, 7.91) 96.7, P ≤ 0.001 REM
de F 8 8.19 (5.58, 10.79) 96.2, P ≤ 0.001 REM
Gender distribution of MetS (IDF) Male 20 3.46 (2.69, 4.23) 96.7, P ≤ 0.001 REM
Female 20 2.99 (2.34, 3.65) 95.6, P ≤ 0.001 REM
Gender distribution of MetS (ATPIII) Male 24 6.24 (4.89, 7.59) 93.9, P < 0.001 REM
Female 26 6.51(4.99, 8.03) 95.8, P ≤ 0.001 REM
Gender distribution of MetS (deF.) Male 7 8.78 (5.45, 12.12) 94.3, P ≤ 0.001 REM
Female 7 8.51 (5.21, 11.75) 93.7, P ≤ 0.001 REM
Study Population (IDF) Overweight & Obese 11 1.48 (0.94, 2.01) 87.8, P ≤ 0.001 REM
Othersa 12 0.58 (0.33, 0.82) 93.2, P ≤ 0.001 REM
Study Population (ATP III) Overweight & Obese 18 4.66 (3.49, 5.83) 95.7, P ≤ 0.001 REM
Others 19 2.31 (1.53, 2.72) 95.7, P ≤ 0.001 REM
Study Population (de F.) Overweight & Obese 4 3.95 (1.82, 6.08) 93.3, P ≤ 0.001 REM
Othersa 4 3.20 (0.78, 5.62) 96.4, P ≤ 0.001 REM
Components MetS (IDF) Abdominal obesity 25 18.85 (16.39, 21.31) 98.9, P ≤ 0.001 REM
Low HDL-C 25 27.93 (21.91, 33.96) 99.8, P ≤ 0.001 REM
High TG 26 11.09 (9.13, 13.05) 99.3, P ≤ 0.001 REM
High FG 26 7.78 (6.40, 9.15) 99.0, P ≤ 0.001 REM
Elevated BP 25 8.76 (7.22, 10.29) 99.1, P ≤ 0.001 REM
Components MetS (ATP III) Abdominal obesity 18 4.66 (3.49, 5.83) 95.7, P ≤ 0.001 REM
Low HDL-C 28 31.30 (23.89, 38.72) 99.7, P ≤ 0.001 REM
High TG 28 21.05 (16.63,25.48) 99.4, P ≤ 0.001 REM
High FG 28 6.08 (5.02, 7.15) 98.7, P ≤ 0.001 REM
Elevated BP 27 12.27 (9.39, 15.16) 99.1, P ≤ 0.001 REM
Components MetS (de F.) Abdominal obesity 7 22.65 (14.01, 31.39) 99.3, P ≤ 0.001 REM
Low HDL-C 6 45.83 (34.53, 57.14) 99.1 P ≤ 0.001 REM
High TG 7 17.4 (12.24, 21.84) 97.3 P ≤ 0.001 REM
High FG 7 2.12 (1.15, 3.08) 94.7, P ≤ 0.001 REM
Elevated BP 7 12.86 (7.11, 18.61) 98.7, P ≤ 0.001 REM
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Fig. 4 Pooled prevalence of MetS (a Subgroup analysis using income level; b Subgroup analysis based on continent)
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Fig. 5 Pooled prevalence of MetS (a Subgroup analysis using income level; b Subgroup analysis using continent)
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and LMIE in the IDF criteria. The pooled prevalence of 
MetS in LIE, LMIE, and UMIE countries is 12.4%, 6.91% 
and 12.4%, respectively. However, the prevalence of MetS 
in LMIE (5.3%) is relatively lower than UMIE (7%) coun-
tries in ATP III diagnostic criteria. These findings remind 
that MetS is an emerging crisis in children and adolescent 
without geographical boundary. This could be primar-
ily associated with the nutrition transition in developing 
countries [116].
In addition, MetS was calculated based on the conti-
nent where the original studies were conducted. In the 
IDF criteria, the pooled prevalence in Africa (6.03%) is 
relatively higher than in Asia (4.39%) and Latin Amer-
ica (2.46%). Whereas, the pooled prevalence of MetS in 
Africa (7.02%) and Asia (7.24%) are nearly the same in 
the general population and higher than the prevalence 
in Latin America (5.19%) in the ATP III diagnostic cri-
teria. The rising burden of MetS in the poor continents 
like Africa is corroborated by the fact that the universal 
increment of obesity, the main predictor of MetS in the 
world, including the poorest LMICs [117, 118]. Finally, 
the number of cases was plotted against the publication 
year. It was pinpointed in the line graph that there is an 
increasing trend in the two diagnostic methods (IDF and 
de Ferranti), but the trend decreases from 2004 to 2020 in 
the ATP III diagnostic method. This may be attributed to 
differences in the sample size. The other possible rational 
could be related to variation in the year of publication of 
the original studies.
The findings of this study will have a vital implication 
for program planners and policy makers to design pre-
ventive strategies accordingly. These findings will have 
several implications for the poorest LMICs, where nutri-
tion transition and the triple burden of malnutrition are 
prevailing in recent years. However, the issue of which 
diagnostic method is the best remains unresolved and 
Fig. 6 Funnel plot for the two diagnostic methods (IDF & ATP III)
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this could affect the final conclusion. The other limita-
tion of this study was some articles written other than 
the English language and articles with the difficulty of 
accessing the full texts were excluded. We excluded 
articles which are not written in English because it is dif-
ficult to identify the real estimates of MetS and to assess 
the qualities of studies. Studies conducted among dif-
ferent population, such as studies among children with 
Fig. 7 Sensitivity analysis for two diagnostic methods (IDF & ATPIII)
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type 1 diabetic were excluded to avoid overestimation of 
MetS. This could affect the pooled estimates of MetS and 
components.
Conclusion
In conclusion, this study illustrates that MetS among 
children and adolescents is an emerging public health 
challenge in LMICs where the prevalence of obesity 
is on the move. The prevalence is significantly higher 
among the overweight and obese population. The bur-
den is also rising in low income countries found in 
Asia and Africa. Metabolic syndrome was diagnosed 
in underweight, normal weight, overweight and obese 
children and adolescents, revealing the triple burden of 
malnutrition in these countries. Thus, additional stud-
ies need to be conducted to identify all possible factors. 
Preventive strategies like community based and school 
based interventions on lifestyle modifications may avert 
MetS in LMICs. Specifically, promoting healthy eat-
ing behaviors and physical activities as well as avoiding 
consumption of fructose based drinks may primarily 
decrease the burden.
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